Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
BEFREE |
These data suggest that the reported role of ceruloplasmin cannot fully explain the iron hepatosplenic phenotype in HA, encouraging the search for additional mechanisms.-Kenawi, M., Rouger, E., Island, M.-L., Leroyer, P., Robin, F., Remy, S., Tesson, L., Anegon, I., Nay, K., Derbré, F., Brissot, P., Ropert, M., Cavey, T., Loréal, O. Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia.
|
31560858 |
2019 |
Ceruloplasmin deficiency
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
The essential role of CP in iron metabolism in humans is particularly evident in the case of loss-of-function mutations in the CP gene resulting in a neurodegenerative syndrome known as aceruloplasminaemia.
|
30895493 |
2019 |
Ceruloplasmin deficiency
|
0.900 |
AlteredExpression
|
disease |
BEFREE |
Heterozygosity for aceruloplasminemia invariably causes reduced ceruloplasmin levels, and similarly to previews reports in the literature, our cases did not present with anemia.
|
30901137 |
2019 |
Ceruloplasmin deficiency
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Aceruloplasminemia (ACP) is a rare, adult-onset, autosomal recessive disorder, characterized by systemic iron overload due to mutations in the Ceruloplasmin gene (<i>CP</i>), which in turn lead to absence or strong reduction of CP activity.
|
31024241 |
2019 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
BEFREE |
We investigated the potential of ceruloplasmin replacement therapy in reducing the neurological pathology in the ceruloplasmin-knockout (CpKO) mouse model of aceruloplasminemia.
|
29183916 |
2018 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
BEFREE |
Recent studies in animal models of aceruloplasminemia support the possibility of new therapeutic approaches by parenteral ceruloplasmin administration.
|
30568573 |
2018 |
Ceruloplasmin deficiency
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
We report the case of a patient with hereditary ceruloplasmin deficiency due to a novel gene mutation in ceruloplasmin gene (CP), treated with fresh frozen plasma (FFP) and iron chelation therapy.
|
27817091 |
2017 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
BEFREE |
Ceruloplasmin, a multi-copper oxidase, is mainly involved in iron metabolism and its genetic defect, aceruloplasminemia (ACP), shows neurological disorders and diabetes associated with excessive iron accumulation, but little is known about the state of copper in the brain.
|
27272717 |
2017 |
Ceruloplasmin deficiency
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients.
|
28012953 |
2017 |
Ceruloplasmin deficiency
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
|
26777753 |
2016 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Ceruloplasmin deficiency
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.
|
25864092 |
2015 |
Ceruloplasmin deficiency
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
|
25247888 |
2014 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
BEFREE |
Clinical and pathologic studies in patients with aceruloplasminemia and ceruloplasmin knockout mice revealed increased lipid peroxidation due to iron-mediated cellular radical injury which is caused by a marked accumulation of iron in the affected parenchymal tissues such as the retina, liver, pancreas and brain.
|
22515740 |
2012 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
CTD_human |
Low copper and ceruloplasmin in serum are the diagnostic hallmarks for Menkes disease, Wilson disease, and aceruloplasminemia.
|
22243965 |
2012 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
BEFREE |
Low copper and ceruloplasmin in serum are the diagnostic hallmarks for Menkes disease, Wilson disease, and aceruloplasminemia.
|
22243965 |
2012 |
Ceruloplasmin deficiency
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Homozygous mutations in the ceruloplasmin gene cause aceruloplasminemia, which is characterized by the triad of diabetes, retinopathy, and a neurological disorder in mid adulthood.
|
21496576 |
2011 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
CTD_human |
A novel homozygous ceruloplasmin gene mutation, c.2554+1G>T, was identified as the cause of aceruloplasminemia in three affected siblings.
|
20801540 |
2010 |
Ceruloplasmin deficiency
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
A novel homozygous ceruloplasmin gene mutation, c.2554+1G>T, was identified as the cause of aceruloplasminemia in three affected siblings.
|
20801540 |
2010 |
Ceruloplasmin deficiency
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
The properties of mutant ceruloplasmin regarding the regulation of ferroportin may therefore provide a therapeutic strategy for aceruloplasminemia patients.
|
20655381 |
2010 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
BEFREE |
Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia.
|
19095659 |
2009 |
Ceruloplasmin deficiency
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia.
|
19095659 |
2009 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
MGD |
Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice.
|
18804145 |
2008 |
Ceruloplasmin deficiency
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to elucidate the molecular pathogenesis of aceruloplasminemia by a functional analysis of mutant ceruloplasmin.
|
17637479 |
2007 |
Ceruloplasmin deficiency
|
0.900 |
Biomarker
|
disease |
BEFREE |
The investigation of mutant ceruloplasmin reveals new insights into molecular pathogenesis of aceruloplasminemia as well as biosynthesis, trafficking, and function of ceruloplasmin.
|
16629161 |
2006 |